0913693 B.C. Ltd.

OTCPK:REPC.F Stock Report

Market Cap: US$7.4k

0913693 B.C Management

Management criteria checks 2/4

0913693 B.C's CEO is Andrew Schutte, appointed in Nov 2022, has a tenure of 3.08 years. directly owns 26.33% of the company’s shares, worth $1.94K. The average tenure of the management team and the board of directors is 3.1 years and 9.6 years respectively.

Key information

Andrew Schutte

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.1yrs
CEO ownership26.3%
Management average tenure3.1yrs
Board average tenure9.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Andrew Schutte's remuneration changed compared to 0913693 B.C's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-CA$8m

Jun 30 2025n/an/a

-CA$8m

Mar 31 2025n/an/a

-CA$8m

Dec 31 2024n/an/a

-CA$97k

Sep 30 2024n/an/a

CA$2m

Jun 30 2024n/an/a

CA$763k

Mar 31 2024n/an/a

CA$400k

Dec 31 2023CA$63kCA$48k

-CA$312k

Sep 30 2023n/an/a

-CA$69k

Jun 30 2023n/an/a

-CA$366k

Mar 31 2023n/an/a

-CA$919k

Dec 31 2022CA$9kn/a

-CA$743k

Sep 30 2022n/an/a

-CA$4m

Jun 30 2022n/an/a

-CA$4m

Mar 31 2022n/an/a

-CA$4m

Dec 31 2021CA$15kn/a

-CA$4m

Sep 30 2021n/an/a

-CA$3m

Jun 30 2021n/an/a

-CA$3m

Mar 31 2021n/an/a

-CA$3m

Dec 31 2020CA$14kn/a

-CA$2m

Sep 30 2020n/an/a

-CA$2m

Jun 30 2020n/an/a

-CA$2m

Mar 31 2020n/an/a

-CA$3m

Dec 31 2019CA$12kn/a

-CA$3m

Sep 30 2019n/an/a

-CA$3m

Jun 30 2019n/an/a

-CA$3m

Mar 31 2019n/an/a

-CA$3m

Dec 31 2018CA$13kn/a

-CA$3m

Compensation vs Market: Insufficient data to establish whether Andrew's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Andrew's compensation has increased whilst the company is unprofitable.


CEO

Andrew Schutte (34 yo)

3.1yrs
Tenure
CA$62,917
Compensation

Mr. Andrew Schutte serves as President, Chief Executive Officer & Director of 0913693 B.C. Ltd. (formerly known as RepliCel Life Sciences Inc.) since November 28, 2022.He served as an Independent Director...


Leadership Team

NamePositionTenureCompensationOwnership
Andrew Schutte
President3.1yrsCA$62.92k26.33%
$ 1.9k
Kevin McElwee
Co-Founder & Chief Scientific Officer14.3yrsCA$72.00kno data
David Kwok
Chief Financial Officer2.3yrsCA$40.00kno data
Ben Austring
Chief Legal Officer3.1yrsCA$72.00kno data
3.1yrs
Average Tenure

Experienced Management: REPC.F's management team is considered experienced (3.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Andrew Schutte
President7yrsCA$62.92k26.33%
$ 1.9k
David Hall
Independent Chairman of the Board15yrsCA$24.00k1.59%
$ 117.1
Jean Krutmann
Member of Clinical Advisory Boardno datano datano data
Ross Davidson
Chairman of Clinical Advisory Board12.2yrsno datano data
Peter Lewis
Independent Director14.6yrsCA$17.50k1.23%
$ 90.4
Tsukasa Kumai
Member of Clinical Advisory Boardno datano datano data
Akimichi Morita
Member of Clinical Advisory Board4.6yrsno datano data
Kunihiko Suzuki
Senior Strategic Advisor to Directors4.2yrsno datano data
9.6yrs
Average Tenure
67.5yo
Average Age

Experienced Board: REPC.F's board of directors are considered experienced (9.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/26 18:28
End of Day Share Price 2025/11/03 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

0913693 B.C. Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.